RS
TIL icon

R Squared’s Instil Bio TIL Stock Holding History

R Squared’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20
Closed -$382 – 1399
2024
Q4 		$382 Buy
+20
New +$610 ﹤0.01% 1545

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

R Squared's TIL Position: Q1 2025 in Review

R Squared sold out of Instil Bio (TIL) in Q1 2025, closing a stake of 20 shares — an estimated $382 sold.

R Squared first reported a position in TIL in Q4 2024 and held it in 1 quarter. The position peaked at $382 in Q4 2024. 43 funds tracked by Wall St. Rank hold TIL as of Q1 2025.

  • R Squared reported no remaining Instil Bio position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 20 Instil Bio shares in Q1 2025, an estimated $382.
  • R Squared first reported a position in Instil Bio in Q4 2024 and held it in 1 quarter.
  • R Squared's Instil Bio position peaked at $382 in Q4 2024.
  • 43 funds tracked by Wall St. Rank held Instil Bio as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.